Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

(MENAFN - PR Newswire) STATEN ISLAND, N.Y., Jan. 6, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP ) ("we" or "Acurx" or the "Company"), a late-stage ...Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute